Searched for
INDIAN PHARMACEUTICAL FIRMS
ETMarkets Smart Talk | Time to rotate from expensive smallcaps to large caps? Saurabh Prasad weighs inIn an interaction with Kshitij Anand of ETMarkets, Saurabh Prasad, Head – Research Centre at Mirae Asset Sharekhan, said large caps are now...
Before Xi Jinping's likely India visit, Chinese money is pouring inIndia is cautiously reopening economic channels with China as Chinese linked investment returns after years of restrictions following the G...
NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
Strikes in the Gulf changing rules behind India’s big-money betsIndia Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...
Red Sea blockade threat: Why India’s trade faces a wider supply-chain shockA prolonged disruption could force ships to reroute around the Cape of Good Hope, raising logistics costs while squeezing exporters and add...
Independence Day 2026: The Kolkata chemist who sold foreign medicines, backed Swadeshi and built a pharma empireIndependence Day 2026: Butto Kristo Paul & Co. started as a modest establishment focused on importing foreign medicines. Over time, it blos...
Need one or two Indian pharma firms to be among global top 5: PM ModiPrime Minister Modi urged Indian pharmaceutical companies to reach global top five. The Indian pharma industry ranks third globally by volu...
India-UAE Business Expansion Forum: The next growth frontier for Indian SMEsAs Indian businesses look beyond exports towards building a lasting international presence, the India-UAE Business Expansion Forum will exp...
Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
India sets sail to add more trade muscle as it signs PTA terms with SACUIndia and the Southern African Customs Union signed terms to start trade negotiations. This move revives talks after previous rounds stalle...
Q1 Earnings Scorecard: Strong demand drives revenue, input costs hit profitsSustained market demand led to impressive revenue growth in the automotive and consumer goods sectors. In contrast, while the banking secto...
Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisionsNew rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has am...
India's big billion-dollar trade deals are done. Now comes the real testIndia has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...
Uzbekistan invites Indian firms for mining, minerals push ahead of PM Modi's visitIn a bid to enhance economic ties, Uzbekistan is inviting Indian investments into its mining and metallurgy sectors, highlighting lucrative...
India Inc goes on a global shopping spree with a new wishlistIndian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...
India, Uzbekistan could explore FTA, says Piyush Goyal; Uzbekistan invites Indian investment in mining, rare earthsIndia and Uzbekistan aim to double bilateral trade to three billion dollars within three years. Businesses are urged to increase investment...
India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...